IP Library Assignment 036714/0719
Patent Assignment
Reel/Frame 036714/0719

Security Interest

Recorded: 2015-09-29 Pages: 17
Assignor
TRIPEP AB
Executed: 2015-09-11
Assignee
KNOBBE, MARTENS, OLSON & BEAR, LLP
2040 MAIN STREET, 14TH FLOOR, IRVINE, CALIFORNIA, 92614
Covered Properties (40)
Antigen/antibody specificity exchanger
Patent: 6,245,895 →
Application: 09/532,106 →
Vaccines Containing Ribavirin and Methods of Use Thereof
Patent: 6,858,590 →
Application: 09/929,955 →
Publication: US 2002/0136740
Hepatitis C Virus Non-Structural NS3/4A Fusion Gene
Patent: 6,960,569 →
Application: 09/930,591 →
Publication: US 2004/0092730
Vaccines Containing Ribavirin and Methods of Use Thereof
Patent: 6,680,059 →
Application: 10/104,966 →
Publication: US 2002/0155124
Hepatitis C Virus Codon Optimized Non-Structural NS3/4A Fusion Gene
Patent: 7,022,830 →
Application: 10/307,047 →
Publication: US 2003/0206919
Specificity Exchangers That Redirect Antibodies to Bacterial Adhesion Receptors
Patent: 6,933,366 →
Application: 10/372,735 →
Publication: US 2003/0225251
Glycosylated Ligand/Receptor Specificity Exchangers Specific for Bacterial Adhesion Receptors
Patent: 7,019,111 →
Application: 10/608,541 →
Publication: US 2004/0019189
Vaccines Containing Ribavirin and Methods of Use Thereof
Patent: 7,261,883 →
Application: 10/719,619 →
Publication: US 2004/0086529
Glycosylated Specificity Exchangers
Patent: 7,318,926 →
Application: 10/773,628 →
Publication: US 2005/0019333
Vaccines Containing Ribavirin and Methods of Use Thereof
Patent: 7,241,440 →
Application: 10/817,591 →
Publication: US 2004/0229832
Glycosylated Specificity Exchangers
Patent: 7,335,359 →
Application: 10/913,754 →
Publication: US 2005/0074854
Hepatitis C Virus Codon Optimized Non-Structural NS3/4A Fusion Gene
Patent: 7,307,066 →
Application: 11/043,808 →
Publication: US 2005/0124573
Hepatitis C Virus Non-Structural NS3/4A Fusion Gene
Patent: 7,439,347 →
Application: 11/249,893 →
Publication: US 2006/0062801
Vaccines Containing Ribavirin and Methods of Use Thereof
Patent: 7,244,422 →
Application: 11/409,670 →
Publication: US 2006/0182764
Glycosylated Specificity Exchangers
Patent: 7,534,435 →
Application: 11/411,294 →
Publication: US 2006/0194247
Hepatitis C Virus Codon Optimized Non-Structural NS3/4A Fusion Gene
Patent: 7,223,743 →
Application: 11/411,318 →
Publication: US 2006/0183705
Glycosylated Specificity Exchangers
Patent: 7,332,166 →
Application: 11/411,454 →
Publication: US 2006/0276621
Vaccines Containing Ribavirin and Methods of Use Thereof
Patent: 7,244,715 →
Application: 11/411,493 →
Publication: US 2006/0183699
Hepatitis C Virus Non-Structural NS3/4A Fusion Gene
Patent: 7,226,912 →
Application: 11/411,494 →
Publication: US 2007/0026425
Transgenic Mouse Models of Hepatitis C Virus (Hcv) and Identification of Hvc Therapeutics
Patent: 7,566,812 →
Application: 11/660,878 →
Publication: US 2008/0295185
Hepatitis C Virus Non-Structural NS3/4A Fusion Gene
Patent: 7,968,697 →
Application: 11/915,142 →
Publication: US 2009/0215869
Hepatitis C Virus Codon Optimized Non-Structural NS3/4A Fusion Gene
Patent: 7,638,499 →
Application: 12/001,735 →
Publication: US 2008/0213290
Immunogen Platform
Patent: 8,071,561 →
Application: 12/192,776 →
Publication: US 2009/0074803
Hepatitis C Virus Codon Optimized Non-Structural NS3/4A Fusion Gene
Patent: 7,943,149 →
Application: 12/649,216 →
Publication: US 2010/0104592
Glycosylated Specificity Exchangers
Patent: 8,303,956 →
Application: 12/748,151 →
Publication: US 2010/0183635
Hepatitis C Virus Codon Optimized Non-Structural NS3/4A Fusion Gene
Patent: 8,163,547 →
Application: 12/894,004 →
Publication: US 2011/0065174
Hepatitis C Virus Codon Optimized Non-Structural NS3/4A Fusion Gene
Patent: 8,158,602 →
Application: 12/894,006 →
Publication: US 2011/0082287
Hepatitis C Virus Codon Optimized Non-Structural NS3/4A Fusion Gene
Patent: 8,163,712 →
Application: 12/894,014 →
Publication: US 2011/0081381
Immunogen Platform
Patent: 8,258,275 →
Application: 13/009,824 →
Publication: US 2011/0150922
Compositions and Methods That Enhance an Immune Response
Patent: 8,445,663 →
Application: 13/146,755 →
Publication: US 2012/0039842
Immunogen Platform
Patent: 8,883,169 →
Application: 13/178,373 →
Publication: US 2012/0010394
Hepatitis C Virus Codon Optimized Non-Structural NS3/4A Fusion Gene
Application: 13/441,305 →
Publication: US 2012/0208870
T Cell Receptors Specific for Immunodominant Ctl Epitopes of Hcv
Patent: 9,193,778 →
Application: 13/511,353 →
Publication: US 2013/0011375
Codon-Optimzed Hepatitis B Virus Core Antigen (Hbcag)
Application: 13/514,269 →
Publication: US 2013/0012865
Glycosylated Specificity Exchangers
Patent: 8,658,179 →
Application: 13/654,326 →
Publication: US 2013/0041131
Glycosylated Specificity Exchangers
Patent: 9,079,962 →
Application: 14/085,167 →
Publication: US 2014/0081004
Injection Needle and Device
Patent: 9,457,183 →
Application: 14/125,905 →
Publication: US 2014/0121587
Simple Vaccines from Dna Launched Suicidal Flaviviruses
Application: 14/221,662 →
Publication: US 2014/0286985
Immunogen Platform
Application: 14/527,669 →
Publication: US 2015/0051388
Compositions and Methods That Enhance an Immune Response
Application: 14/692,667 →
Publication: US 2015/0252084
Related Assignments (17)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Apr 1, 2003
From: SALLBERG, MATTI
To: TRIPEP AB
Reel/Frame 013896/0459 →
Assignment of Assignor's Interest May 16, 2003
From: SALLBERG, MATTI; HULTGREN, CATHARINA
To: TRIPEP AB
Reel/Frame 014073/0007 →
Assignment of Assignor's Interest May 19, 2003
From: SALLBERG, MATTI; HULTGREN, CATHARINA
To: TRIPEP AB
Reel/Frame 014075/0114 →
Assignment of Assignor's Interest May 19, 2003
From: SALLBERG, MATTI
To: TRIPEP AB
Reel/Frame 014076/0381 →
Assignment of Assignor's Interest Jun 24, 2003
From: SALLBERG, MATTI; FLOCK, JAN-INGMAR
To: TRIPEP AB
Reel/Frame 014194/0536 →
Assignment of Assignor's Interest Nov 3, 2003
From: SALLBERG, MATTI
To: TRIPEP AB
Reel/Frame 014650/0248 →
Assignment of Assignor's Interest Sep 8, 2004
From: SALLBERG, MATTI
To: TRIPEP AB
Reel/Frame 015114/0887 →
Assignment of Assignor's Interest Dec 6, 2004
From: SALLBERG, MATTI
To: TRIPEP AB, A SWEDISH CORPORATION
Reel/Frame 016044/0941 →
Assignment of Assignor's Interest Nov 29, 2005
From: SALLBERG, MATTI
To: TRIPEP AB
Reel/Frame 017074/0284 →
Assignment of Assignor's Interest Nov 13, 2007
From: SALLBERG, MATTI; VAHLNE, ANDERS; PERDOMO, MARIA
To: TRIPEP AB
Reel/Frame 020108/0628 →
Assignment of Assignor's Interest Nov 13, 2007
From: SALLBERG, MATTI; VAHLNE, ANDERS; PERDOMO, MARIA
To: TRIPEP AB
Reel/Frame 020108/0621 →
Assignment of Assignor's Interest Nov 13, 2007
From: SALLBERG, MATTI; VAHLNE, ANDERS; PERDOMO, MARIA
To: TRIPEP AB
Reel/Frame 020108/0618 →
Assignment of Assignor's Interest Nov 13, 2007
From: SALLBERG, MATTI; VAHLNE, ANDERS; PERDOMO, MARIA
To: TRIPEP AB
Reel/Frame 020108/0406 →
Change of Name Apr 14, 2010
From: TRIPEP AB
To: CHRONTECH PHARMA AB
Reel/Frame 024233/0094 →
Assignment of Assignor's Interest Dec 9, 2014
From: AVAC PHARMA LIMITED
To: CHRONTECH PHARMA AB
Reel/Frame 034442/0817 →
Assignment of Assignor's Interest Dec 9, 2014
From: CHRONTECH PHARMA AB
To: AVAC PHARMA LIMITED
Reel/Frame 034442/0805 →
Assignment of Assignor's Interest Dec 16, 2014
From: CHRONTECH PHARMA AB
To: TRIPEP AB
Reel/Frame 034521/0261 →